Monica M. Farley

40.3k citations

235 papers · 28.0k indexed · 16 hit papers · h-index 79

Epidemiology top 0.01%
Infectious Diseases top 0.05%
Public Health, Environmental and Occupational Health top 0.05%
Microbiology top 0.01%
Molecular Biology top 5%

Co-authors: Lee H. Harrison Arthur Reingold Anne Schuchat Ruth Lynfield Cynthia G. Whitney James L. Hadler William Schaffner Nancy M. Bennett
Topics: Pneumonia and Respiratory Infections (114 papers)Bacterial Infections and Vaccines (61 papers)Respiratory viral infections research (57 papers)
Cited by: Microbiology Epidemiology Infectious Diseases
Journals: New England Journal of Medicine The Lancet JAMA
Partner nations: United States Uganda Canada

In The Last Decade

Monica M. Farley

227 papers receiving 27.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Burden of Clostridium difficile Infection in the United States

2015 2.0k citations Yi Mu, Wendy Bamberg et al. profile →
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

2003 1.7k citations Cynthia G. Whitney, Monica M. Farley et al. profile →
Methicillin-ResistantStaphylococcus aureusDisease in Three Communities

2005 1.2k citations Scott K. Fridkin, Lee H. Harrison et al. profile →
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

2009 1.0k citations Tamara Pilishvili, Catherine Lexau et al. profile →
Bacterial Meningitis in the United States in 1995

1997 934 citations Anne Schuchat, Jay D. Wenger et al. profile →
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis

2000 759 citations Stephanie J. Schrag, Monica M. Farley et al. profile →
Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United States

2000 691 citations Cynthia G. Whitney, Monica M. Farley et al. profile →
Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae

2006 653 citations Ruth Lynfield, William Schaffner et al. profile →
Bacterial Meningitis in the United States, 1998–2007

2011 632 citations Cynthia G. Whitney, Elizabeth R. Zell et al. profile →
Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004

2007 609 citations Lee H. Harrison, James L. Hadler et al. profile →
Cigarette Smoking and Invasive Pneumococcal Disease

2000 578 citations J. Pekka Nuorti, Monica M. Farley et al. profile →
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes

2020 529 citations Alice Guh, Yi Mu et al. profile →
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

2006 503 citations Cynthia G. Whitney, Monica M. Farley et al. The Lancet profile →
Active Bacterial Core Surveillance of the Emerging Infections Program Network

2001 501 citations Anne Schuchat, Elizabeth R. Zell et al. profile →
Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014

2016 300 citations Stephanie J. Schrag, Monica M. Farley et al. PEDIATRICS profile →
Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015

2019 254 citations Susan Petit, Mirasol Apostol et al. profile →

Peers

Countries citing papers authored by Monica M. Farley

Since Specialization

Citations

This map shows the geographic impact of Monica M. Farley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica M. Farley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica M. Farley more than expected).

Fields of papers citing papers by Monica M. Farley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica M. Farley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica M. Farley. The network helps show where Monica M. Farley may publish in the future.

Co-authorship network of co-authors of Monica M. Farley

This figure shows the co-authorship network connecting the top 25 collaborators of Monica M. Farley. A scholar is included among the top collaborators of Monica M. Farley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica M. Farley. Monica M. Farley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mpox among people reporting being unhoused or engaging in transactional sex within a multijurisdictional case-control study of sexually and gender minoritized individuals— United States, August 2022–March 2024 2025 ·Social Science & Medicine ·(unknown),(unknown),Linda M. Niccolai,(unknown),(unknown),Melissa Sutton,S. R. Hawkins,Preeti Pathela,(unknown),Gretchen Rothrock,Joelle Nadle,Jemma V. Rowlands,Christina B. Felsen,Amber Britton,Monica M. Farley,(unknown),Kevin Kamis,(unknown),Allison S. Morrow,(unknown)	0
2	Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study 2024 ·Vaccine ·Kristin L. Andrejko,Ryan Gierke,Jemma V. Rowlands,Jennifer B. Rosen,Ann Thomas,(unknown),María Rosales,(unknown),William Schaffner,Corinne Holtzman,Meghan Barnes,Monica M. Farley,Lee H. Harrison,Lesley McGee,Sopio Chochua,Jennifer R. Verani,Adam L. Cohen,Tamara Pilishvili,Miwako Kobayashi	15
3	Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis—Georgia, United States, 2021 2024 ·Open Forum Infectious Diseases ·Elizabeth Misas,Lucy S Witt,Monica M. Farley,Stepy Thomas,(unknown),Lalitha Gade,(unknown),(unknown),Scott K. Fridkin,Shawn R. Lockhart,Nancy A. Chow,Meghan Lyman	8
4	Absence of mgrB Alleviates Negative Growth Effects of Colistin Resistance in Enterobacter cloacae 2020 ·Antibiotics ·(unknown),Aroon T. Chande,Eileen M. Burd,Victor I. Band,Sarah W. Satola,Monica M. Farley,Jesse T. Jacob,I. King Jordan,David S. Weiss	5
5	Carbapenem-resistant Enterobacterales bacteriuria and subsequent bacteremia: A population-based study 2020 ·Infection Control and Hospital Epidemiology ·Jessica Howard‐Anderson,Chris Bower,Gillian Smith,(unknown),Monica M. Farley,Sarah W. Satola,Jesse T. Jacob	5
6	Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015 2018 ·American Journal of Infection Control ·Alice Guh,Yi Mu,James Baggs,Lisa G. Winston,Wendy Bamberg,Carol Lyons,Monica M. Farley,Lucy Wilson,Stacy Holzbauer,Erin C. Phipps,Zintars G. Beldavs,Marion Kainer,Maria Karlsson,Dale N. Gerding,Ghinwa Dumyati	17
7	Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012 2015 ·PEDIATRICS ·Jessica R. MacNeil,Nancy M. Bennett,Monica M. Farley,Lee H. Harrison,Ruth Lynfield,Megin Nichols,(unknown),Arthur Reingold,William Schaffner,Ann Thomas,Tracy Pondo,Leonard W. Mayer,Thomas A. Clark,Amanda Cohn	32
8	Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia 2015 ·The Pediatric Infectious Disease Journal ·(unknown),Dolly Sharma,Emily K. Crispell,Wendy Baughman,Stepy Thomas,Amy Tunali,(unknown),(unknown),Robert Jerris,Sarah W. Satola,Bernard Beall,Matthew R. Moore,Shabnam Jain,Monica M. Farley	95
9	Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae 2015 ·Frontiers in Microbiology ·Scott Chancey,Sonia Agrawal,Max R. Schroeder,Monica M. Farley,(unknown),David S. Stephens	52
10	Socioeconomic and Racial Disparities of Pediatric Invasive Pneumococcal Disease After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine 2013 ·The Pediatric Infectious Disease Journal ·Jennifer O. Spicer,Stephanie Thomas,(unknown),Wendy Baughman,Monica M. Farley	12
11	Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine 2012 ·The Pediatric Infectious Disease Journal ·Dolly Sharma,Wendy Baughman,(unknown),Stephanie Thomas,Delois Jackson,Maria da Glória Carvalho,Bernard Beall,Sarah W. Satola,Robert Jerris,Shabnam Jain,Monica M. Farley,J. Pekka Nuorti	68
12	Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children 2012 ·Clinical Infectious Diseases ·(unknown),Reena Oza‐Frank,Elizabeth R. Zell,Ruth Link‐Gelles,K.M. Venkat Narayan,William Schaffner,Ann Thomas,Catherine Lexau,Nancy M. Bennett,Monica M. Farley,Laura Harrison,Arthur Reingold,James L. Hadler,Bernard Beall,K P Klugman,Matthew R. Moore	71
13	The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008 2011 ·The Pediatric Infectious Disease Journal ·Emily Weston,Tracy Pondo,Melissa Lewis,(unknown),Craig Morin,(unknown),(unknown),Mirasol Apostol,(unknown),Monica M. Farley,Ruth Lynfield,Art Reingold,Nellie I. Hansen,Barbara J. Stoll,Andi L. Shane,Elizabeth R. Zell,Stephanie J. Schrag	373
14	FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance 2010 ·Antimicrobial Agents and Chemotherapy ·(unknown),Naureen Iqbal,(unknown),Monica M. Farley,Lee H. Harrison,Tom Chiller,Shawn R. Lockhart	109
15	Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease 2008 ·The Pediatric Infectious Disease Journal ·Hannah Jordan,Monica M. Farley,Allen S. Craig,Janet C. Mohle‐Boetani,Lee H. Harrison,Susan Petit,Ruth Lynfield,Ann Thomas,Shelley M. Zansky,Kenneth Gershman,Bernadette Albanese,William Schaffner,Stephanie J. Schrag	145
16	Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.(Clinical report) 2006 ·The Lancet ·Katherine L. O’Brien,Orin S. Levine,Cynthia G. Whitney,(unknown),Monica M. Farley,(unknown),Allen S. Craig,Ruth Lynfield,Ann‐Christine Nyquist,Kenneth Gershman,Marietta Vázquez,Nancy M. Bennett,Arthur Reingold,Ann Thomas,Mary P. Glodé,Elizabeth R. Zell,James H. Jorgensen,Bernard Beall,Anne Schuchat	61
17	Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment 2005 ·The Lancet ·David S. Stephens,Susu M. Zughaier,Cynthia G. Whitney,Wendy Baughman,Lawrence Barker,Kathryn Gay,Delois Jackson,Walter A. Orenstein,Kathryn E. Arnold,Anne Schuchat,Monica M. Farley	133
18	Active Bacterial Core Surveillance of the Emerging Infections Program Network 2001 ·SHILAP Revista de lepidopterología ·Anne Schuchat,(unknown),Elizabeth R. Zell,Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis B. Lefkowitz,Richard Danila,Karen Stefonek,Nancy Barrett,Dale L. Morse,Robert W. Pinner	12
19	Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis 2000 ·Obstetrical & Gynecological Survey ·Stephanie J. Schrag,(unknown),Monica M. Farley,Arthur Reingold,Lee H. Harrison,Lewis B. Lefkowitz,James L. Hadler,Richard Danila,Paul R. Cieslak,Anne Schuchat	42
20	Invasive Haemophilus influenzae Disease in Adults 1992 ·Annals of Internal Medicine ·Monica M. Farley,David S. Stephens,Philip S. Brachman,(unknown),(unknown),Jay D. Wenger,(unknown)	99

About Monica M. Farley

Monica M. Farley is a scholar working on Microbiology, Epidemiology and Infectious Diseases, having authored 235 papers that have together received 28.0k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (114 papers), Bacterial Infections and Vaccines (61 papers) and Respiratory viral infections research (57 papers). The work is most often cited by research in Microbiology (6.8k citations), Epidemiology (18.8k citations) and Infectious Diseases (9.4k citations). Monica M. Farley has collaborated with scholars based in United States, Uganda and Canada. Frequent co-authors include Lee H. Harrison, Arthur Reingold, Anne Schuchat, Ruth Lynfield, Cynthia G. Whitney, James L. Hadler, William Schaffner, Nancy M. Bennett, Ann Thomas and Paul R. Cieslak. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact